Zhao Yulin, Lu Xuanzhuang, Wang Runchen, Dai Keyao, Yu Huiwen, Pan Chongde, Zhang Jiaqin, Fan Xianzhe, Lin Yanwei, Liang Hengrui, He Jianxing, Wang Wei, Lan Lan
Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Nanshan School, Guangzhou Medical University, Guangzhou, China.
Transl Lung Cancer Res. 2024 Dec 31;13(12):3555-3565. doi: 10.21037/tlcr-24-725. Epub 2024 Dec 27.
The benefits of spontaneous ventilation (SV)-video-assisted thoracoscopic surgery (VATS) in octogenarian patients with non-small-cell lung cancer (NSCLC) have rarely been reported. This retrospective study was conducted to evaluate the safety and feasibility of SV-VATS in octogenarian patients with NSCLC.
Patients with NSCLC aged >80 years who underwent SV-VATS or mechanical ventilation (MV)-VATS between 2017 and 2022 were included in this study. The baseline characteristics of the two groups were balanced by a 1:2 propensity score matching (PSM). Intraoperative and postoperative outcomes were compared. Overall survival (OS) and disease-free survival (DFS) were analyzed by Kaplan-Meier survival analysis and Cox regression.
A total of 251 patients were initially included, and after applying selection criteria and PSM, 22 patients were in the SV-VATS group and 44 in the MV-VATS group. Baseline characteristics were well balanced between the two groups. Compared with the MV-VATS group, the SV-VATS group had shorter post-anesthesia care unit (PACU) stay (88.8±22.3 111±38.8, P=0.01) and shorter resuscitation time (88.8±22.7 112±40.4, P=0.02). No statistically significant differences were observed in the surgical and anaesthesia times, chest tube duration, total volume of chest drainage, intraoperative blood loss, postoperative hospital stay, or complications in the PACU. The OS and DFS of patients who underwent SV-VATS were comparable to those of patients who underwent MV-VATS.
SV-VATS appears to be a safe and feasible option for octogenarian patients with NSCLC, providing a new approach to surgical treatment. Large-scale prospective studies are required to further validate its feasibility.
关于非小细胞肺癌(NSCLC)老年患者行自主通气(SV)-电视辅助胸腔镜手术(VATS)的益处鲜有报道。本回顾性研究旨在评估SV-VATS在NSCLC老年患者中的安全性和可行性。
纳入2017年至2022年间接受SV-VATS或机械通气(MV)-VATS的年龄>80岁的NSCLC患者。通过1:2倾向评分匹配(PSM)使两组的基线特征达到平衡。比较术中及术后结果。采用Kaplan-Meier生存分析和Cox回归分析总生存期(OS)和无病生存期(DFS)。
最初共纳入251例患者,应用选择标准和PSM后,SV-VATS组有22例患者,MV-VATS组有44例患者。两组基线特征平衡良好。与MV-VATS组相比,SV-VATS组在麻醉后监护病房(PACU)的停留时间更短(88.8±22.3对111±38.8,P = 0.01),复苏时间更短(88.8±22.7对112±40.4,P = 0.02)。在手术时间、麻醉时间、胸管留置时间、胸腔引流量、术中失血量、术后住院时间或PACU并发症方面未观察到统计学显著差异。接受SV-VATS患者的OS和DFS与接受MV-VATS患者相当。
SV-VATS似乎是NSCLC老年患者安全可行的选择,为手术治疗提供了一种新方法。需要大规模前瞻性研究进一步验证其可行性。